Halfprin 162mg. was the first and still the only one half dose enteric coated aspirin on the market. It was specifically developed for low dose aspirin therapy, and is the most appropriate dose for many adults. Low dose aspirin therapy is recommended by Physicians in the prevention of heart attacks and strokes in consumers with certain risk factors. Halfprin 162 mg. is also the dose recommended for use during a suspected heart attack. For those individuals that may need a lower aspirin dose, Halfprin 81mg. is available.

Low dose aspirin regimens are being studied for other potential health benefits. To learn more about low dose aspirin therapy, heart attack and stroke risk factors, and Halfprin, visit www.halfprin.com.